Radiobiology for Children's Health Program, Research Center for Radiation Protection, National Institute of Radiological Sciences, Chiba, Japan ; Radiation Effect Accumulation and Prevention Project, Fukushima Project Headquarters, National Institute of Radiological Sciences, Chiba, Japan.
PLoS One. 2013 Sep 6;8(9):e74013. doi: 10.1371/journal.pone.0074013. eCollection 2013.
BRIP1 is a DNA helicase that directly interacts with the C-terminal BRCT repeat of the breast cancer susceptibility protein BRCA1 and plays an important role in BRCA1-dependent DNA repair and DNA damage-induced checkpoint control. Recent studies implicate BRIP1 as a moderate/low-penetrance breast cancer susceptibility gene. However, the phenotypic effects of BRIP1 dysfunction and its role in breast cancer tumorigenesis remain unclear. To explore the function of BRIP1 in acinar morphogenesis of mammary epithelial cells, we generated BRIP1-knockdown MCF-10A cells by short hairpin RNA (shRNA)-mediated RNA interference and examined its effect in a three-dimensional culture model. Genome-wide gene expression profiling by microarray and quantitative RT-PCR were performed to identify alterations in gene expression in BRIP1-knockdown cells compared with control cells. The microarray data were further investigated using the pathway analysis and Gene Set Enrichment Analysis (GSEA) for pathway identification. BRIP1 knockdown in non-malignant MCF-10A mammary epithelial cells by RNA interference induced neoplastic-like changes such as abnormal cell adhesion, increased cell proliferation, large and irregular-shaped acini, invasive growth, and defective lumen formation. Differentially expressed genes, including MCAM, COL8A1, WIPF1, RICH2, PCSK5, GAS1, SATB1, and ELF3, in BRIP1-knockdown cells compared with control cells were categorized into several functional groups, such as cell adhesion, polarity, growth, signal transduction, and developmental process. Signaling-pathway analyses showed dysregulation of multiple cellular signaling pathways, involving LPA receptor, Myc, Wnt, PI3K, PTEN as well as DNA damage response, in BRIP1-knockdown cells. Loss of BRIP1 thus disrupts normal mammary morphogenesis and causes neoplastic-like changes, possibly via dysregulating multiple cellular signaling pathways functioning in the normal development of mammary glands.
BRIP1 是一种 DNA 解旋酶,它可以直接与乳腺癌易感蛋白 BRCA1 的 C 端 BRCT 重复序列相互作用,并在 BRCA1 依赖性 DNA 修复和 DNA 损伤诱导的检查点控制中发挥重要作用。最近的研究表明 BRIP1 是中度/低外显率乳腺癌易感基因。然而,BRIP1 功能障碍的表型效应及其在乳腺癌肿瘤发生中的作用仍不清楚。为了探讨 BRIP1 在乳腺上皮细胞腺泡形态发生中的功能,我们通过短发夹 RNA (shRNA) 介导的 RNA 干扰生成 BRIP1 敲低 MCF-10A 细胞,并在三维培养模型中检测其作用。通过微阵列进行全基因组基因表达谱分析,并进行定量 RT-PCR 以鉴定 BRIP1 敲低细胞与对照细胞相比基因表达的变化。使用途径分析和基因集富集分析 (GSEA) 进一步研究微阵列数据以鉴定途径。通过 RNA 干扰在非恶性 MCF-10A 乳腺上皮细胞中敲低 BRIP1 会诱导类似肿瘤的变化,如异常细胞黏附、细胞增殖增加、大而不规则的腺泡、侵袭性生长和管腔形成缺陷。与对照细胞相比,BRIP1 敲低细胞中差异表达的基因,包括 MCAM、COL8A1、WIPF1、RICH2、PCSK5、GAS1、SATB1 和 ELF3,可分为几个功能组,如细胞黏附、极性、生长、信号转导和发育过程。信号通路分析显示,BRIP1 敲低细胞中多个细胞信号通路失调,涉及 LPA 受体、Myc、Wnt、PI3K、PTEN 以及 DNA 损伤反应。BRIP1 的缺失因此破坏了正常的乳腺形态发生并导致类似肿瘤的变化,可能是通过失调多个在乳腺正常发育中起作用的细胞信号通路。